| |
|
|
|
 |
|
|
 |
|
|
:: Last Update ::
ÂѧäÁèÁÕ¡ÒûÃѺ»Ãا¢éÍÁÙÅ
|
ËÁÒÂàÅ¢â·ÃÈѾ·ì ::
ÍÕàÁÅì ::
âÎÁྨÊèǹµÑÇ ::
|
|
| »ÃÐÇѵԡÒÃÈÖ¡ÉÒ :: |
| |
- Bachelor of Pharmacy (First Class Honors), Pharmaceutical Sciences, Prince of Songkla University, 2006 |
| |
- Master of Pharmacy (SAP), Social and Administrative Pharmacy, Prince of Songkla University, 2008 |
| |
- Doctor of Philosophy, Health Research Methodology (Health Technology Assessment), McMaster University, CANADA , 2017 |
| §Ò¹ÇԨѷÕèʹ㨠:: |
| |
- Health Technology Assessment; Cost analysis; Healthcare Research |
| ÊÒ¢Ò·ÕèàªÕèÂÇªÒ :: |
| |
- Health Technology Assessment |
| |
º·¤ÇÒÁÇԨѵվÔÁ¾ìã¹ÇÒÃÊÒÃÇÔªÒ¡Òà :: |
| |
1. |
Tanvejsilp P, Taychakhoonavudh S, Chaikledkaew U, Chaiyakunapruk N, Ngorsuraches S. Revisit Roles of HTA on Drug Policy in Universal Health Coverage in Thailand: Where Are We? And What Is Next? . Value in Health Regional Issues. , 18: 78-82, 2019. |
| |
2. |
Tanvejsilp P, Loeb M, Dushoff J, Xie F. Healthcare resource uses and out-of-pocket expenses associated with pulmonary TB treatment in Thailand. . PharmacoEconomics Open, Sep;2(3): 297-308., 2018. |
| |
3. |
Tanvejsilp P, Loeb M, Dushoff J, Xie F. Out of pocket expenditures, indirect costs, and health –related quality of life of patients with pulmonary tuberculosis in Thailand. . PharmacoEconomics Openÿ, Sep;2(3): 281-296., 2018. |
| |
4. |
Tanvejsilp P, Pullenayegum E, Loeb M, Dushoff J, Xie F. Role of pharmaceutical care for self-administered pulmonary tuberculosis treatment in Thailand. . J Clin Pharm Ther , 42(3):: 337-344., 2017. |
| |
5. |
Tanvejsilp P, Ngorsuraches S. Defining the scope of health technology assessment and types of health economic evaluation.. J Med Assoc Thai, 97 Suppl 5: S10-16., 2014. |
| |
6. |
Xie F, Tanvejsilp P, Campbell K, Gaebel K. Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluation. . Drugs Aging , 30(5): 277-284., 2013. |
| |
7. |
Ngorsuraches S, Wanishayakorn T, Tanvejsilp P, Udomaksorn S. Relative importance of attributes of drug benefit plans: Thai civil servants' perspective.. Res Social Adm Pharm , 9(6): 731-740., 2013. |
| |
º·¤ÇÒÁÇÔ¨ÑÂàʹÍã¹·Õè»ÃЪØÁÇÔªÒ¡ÒÃáÅÐÁÕ¡ÒþÔÁ¾ìÃÇÁàÅèÁ :: |
| |
»ÃÐàÀ·Ë¹Ñ§Ê×ÍáÅеÓÃÒ :: |
| |
1. |
¾ÔÁ¾ìÇÃÒ µÑ¹àǪÈÔÅ»ì, ÊØéѵà §éÍÊØÃàªÉ°ì 2014, ¡ÒáÓ˹´¢Íºà¢µ¡ÒûÃÐàÁԹ෤â¹âÅÂÕ´éÒ¹ÊØ¢ÀÒ¾áÅÐÇÔ¸Õ¡ÒûÃÐàÁÔ¹¤ÇÒÁ¤ØéÁ¤èÒ·Ò§ÊÒ¸ÒóÊØ¢. ã¹: ¤ÙèÁ×Í¡ÒûÃÐàÁԹ෤â¹âÅÂÕ´éÒ¹ÊØ¢ÀÒ¾ÊÓËÃѺ»ÃÐà·Èä·Â ©ºÑº·Õè 2 ¾.È. 2556 , âç¾ÔÁ¾ìÇѪÃÔ¹·Ãì ¾Õ.¾Õ. ¨Ó¹Ç¹Ë¹éÒ 271 |
| |
§Ò¹ÇÔªÒ¡ÒûÃÐàÀ·Í×è¹æ (àªè¹ ÊÔ觻ÃдÔÉ°ì ÊÔ·¸ÔºÑµÃ ÏÅÏ) :: |
|